Millbrae, CA, United States of America

Jeffrey Dener

This inventor holds 2 USPTO granted patents. Top assignee: Virobay, Inc.. Active years: 2012-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey Dener. Retrieved from https://idiyas.com/inventor/jeffrey-dener

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Jeffrey Dener

Introduction

Jeffrey Dener is an accomplished inventor based in Millbrae, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for various diseases. With a total of two patents to his name, Dener's work is recognized for its potential impact on medical treatments.

Latest Patents

Dener's latest patents include a process for the preparation of (3S)-3-amino-N-cyclopropyl-2-hydroxyalkanamide derivatives. This invention relates to a method for creating (2S,3S)-3-amino-N-cyclopropyl-2-hydroxyalkanamides, which are useful in the preparation of HCV inhibitors and cathepsin inhibitors. His second patent also focuses on a similar process for the preparation of (3S)-3-amino-N-cyclopropyl-2-hydroxyalkanamide derivatives, emphasizing the creation of novel compounds used in this innovative process.

Career Highlights

Jeffrey Dener is currently associated with Virobay, Inc., where he continues to advance his research and development efforts. His work at Virobay has positioned him at the forefront of pharmaceutical innovation, contributing to the development of new therapeutic agents.

Conclusion

Jeffrey Dener's contributions to the field of pharmaceuticals through his patents and work at Virobay, Inc. highlight his role as a significant inventor in the industry. His innovative processes have the potential to lead to important advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…